Literature DB >> 5042867

Glycopyrrolate as a substitute for atropine in neostigmine reversal of muscle relaxant drugs.

S Ramamurthy, M H Shaker, A P Winnie.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5042867     DOI: 10.1007/bf03005964

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN: 0008-2856


× No keyword cloud information.
  14 in total

1.  A comparison of the antisecretory and vagolytic effects of the belladonna alkaloids and certain synthetic parasympatholytic drugs.

Authors:  W TROTTI; J ADRIANI
Journal:  Surgery       Date:  1958-09       Impact factor: 3.982

2.  Atropine, scopolamine, and related compounds.

Authors:  E I EGER
Journal:  Anesthesiology       Date:  1962 May-Jun       Impact factor: 7.892

3.  Effects of atropine on cardiac rhythm in conscious and anesthetized man.

Authors:  R E JONES; S DEUTSCH; H TURNDORF
Journal:  Anesthesiology       Date:  1961 Jan-Feb       Impact factor: 7.892

4.  Atropine, neostigmine and sudden deaths.

Authors:  H E POOLER
Journal:  Anaesthesia       Date:  1957-04       Impact factor: 6.955

5.  Cardiac arrest following the administration of neostigmine.

Authors:  J I LAWSON
Journal:  Br J Anaesth       Date:  1956-07       Impact factor: 9.166

6.  Anticholinergic drugs in preanesthetic medication.

Authors:  C R STEPHEN; M A BOWERS; W K NOWILL; R C MARTIN
Journal:  Anesthesiology       Date:  1956-03       Impact factor: 7.892

7.  [Curare and prostigmine; two cases of death caused by cardiac syncope after prostigmine administration].

Authors:  G WAQUET
Journal:  Mars Chir       Date:  1951 May-Jun

8.  Safe reversal. 2. Atropine-neostigmine mixture: an electrocardiographic study.

Authors:  A Baraka
Journal:  Br J Anaesth       Date:  1968-01       Impact factor: 9.166

9.  Effects of administration of atropine and neostigmine in man.

Authors:  A Ovassapian
Journal:  Anesth Analg       Date:  1969 Mar-Apr       Impact factor: 5.108

10.  Atropine sulfate vs atropine methyl bromide. Effect on maternal and fetal heart rate.

Authors:  C B De Padua; J S Gravenstein
Journal:  JAMA       Date:  1969-05-12       Impact factor: 56.272

View more
  10 in total

1.  Anesthesiology-epitomes of progress: glycopyrrolate: a challenge to atropine.

Authors:  K S Ching
Journal:  West J Med       Date:  1978-02

2.  Anesthesiology: present status of muscle relaxants and antagonists.

Authors:  L Gyermek
Journal:  West J Med       Date:  1976-10

3.  Glycopyrrolate methobromide: 2. comparison with atropine sulphate in anaesthesia.

Authors:  K A Oduro
Journal:  Can Anaesth Soc J       Date:  1975-07

Review 4.  Anticholinergic drugs and anaesthesia.

Authors:  R K Mirakhur
Journal:  Can J Anaesth       Date:  1988-09       Impact factor: 5.063

5.  Atrophine, scopolamine, and glycopyrrolate.

Authors:  A Fassi; M Rosenberg
Journal:  Anesth Prog       Date:  1979 Nov-Dec

6.  Comparison of the effects of atropine and glycopyrrolate on various end-organs.

Authors:  R K Mirakhur; J W Dundee
Journal:  J R Soc Med       Date:  1980-10       Impact factor: 5.344

7.  Evaluation of the anticholinergic actions of glycopyrronium bromide.

Authors:  R K Mirakhur; J W Dundee; C J Jones
Journal:  Br J Clin Pharmacol       Date:  1978-01       Impact factor: 4.335

8.  Anatomical dead space and airway resistance after glycopyrrolate or atropine premedication.

Authors:  A W Gotta; C Ray; C A Sullivan; P L Goldiner
Journal:  Can Anaesth Soc J       Date:  1981-01

9.  Effect of halogenated anaesthetics on heart rate changes during reversal of neuromuscular block with glycopyrrolate and neostigmine.

Authors:  S K Samra; U Pandit; S K Pandit; S P Kothary
Journal:  Can Anaesth Soc J       Date:  1984-11

10.  Glycopyrrolate versus atropine for preventing bradycardia induced by neostigmine injection after general anesthesia surgery: a randomized open, parallel-controlled multicenter clinical trial.

Authors:  Yue Yun; Dianqing Cao; Xiaoqing Zhang; Wen Ouyang; Su Min; Jianrui Lv; Lin Li; Furong Huang
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.